2016 has proved an eventful year on the international scene and one that will no doubt spark changes to the world of clinical trials. With the announcements of Brexit and a new US president, many in the industry are rightly seeking guidance for what changes 2017 could bring for professionals working within the industry. Beyond political changes, trial sponsors will also have to adapt to operational changes in the wake of new EU regulations. Despite this, the pillars of successful trials still remain rooted in good working relationships and strong communication channels.
The 4th edition of the Clinical Trial Yearbook serves as an accessible reference point for this rapidly evolving industry.